Abstract: The present disclosure provides a healthcare management method comprising acquiring a first data that includes a glycoalbumin concentration and an albumin concentration in a body fluid from a subject; generating, on the basis of the first data, output information related to the GA value; and providing the generated output information to a user.

Abstract: [Problem to be Solved] A biosensor having high detection sensitivity and detection specificity is provided. [Solution] There is provided a biosensor comprising: an identification substance capable of binding to a substance to be detected; and an electrode charged with a charge of the identification substance, and detecting a change in a charge density of the electrode caused by binding of the substance to be detected to the identification substance, wherein a polymer layer in which a molecular template having a structure complementary to a molecular structure of the substance to be detected is formed is formed on all or part of a surface of the electrode, the identification substance is contained in the polymer layer, and the polymer layer is an ultrathin film layer.

Abstract: [Problem to be Solved] A biosensor having high detection sensitivity and detection specificity is provided. [Solution] There is provided a biosensor comprising: an identification substance capable of binding to a substance to be detected; and an electrode charged with a charge of the identification substance, and detecting a change in a charge density of the electrode caused by binding of the substance to be detected to the identification substance, wherein a polymer layer in which a molecular template having a structure complementary to a molecular structure of the substance to be detected is formed is formed on all or part of a surface of the electrode, the identification substance is contained in the polymer layer, and the polymer layer is an ultrathin film layer.